HK$64.75
1.60% yesterday
Hong Kong, Oct 06, 10:08 am CET
ISIN
KYG5074A1004
Symbol
6618
Index

JD Health International Stock price

HK$64.75
+1.70 2.70% 1M
+36.95 132.91% 6M
+36.65 130.43% YTD
+29.50 83.69% 1Y
+15.80 32.28% 3Y
-45.25 41.14% 5Y
-45.25 41.14% 10Y
-45.25 41.14% 20Y
Hong Kong, Closing price Mon, Oct 06 2025
-1.05 1.60%

Key metrics

Basic
Market capitalization
HK$213.5b
Enterprise Value
HK$160.1b
Net debt
positive
Cash
HK$53.9b
Shares outstanding
3.2b
Valuation (TTM | estimate)
P/E
40.6 | 35.5
P/S
3.0 | 2.7
EV/Sales
2.3 | 2.0
EV/FCF
17.7
P/B
3.4
Financial Health
Equity Ratio
77.5%
Return on Equity
7.5%
ROCE
6.7%
ROIC
36.1%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
HK$71.2b | HK$78.1b
EBITDA
- | HK$4.0b
EBIT
HK$4.3b | HK$3.8b
Net Income
HK$5.2b | HK$5.9b
Free Cash Flow
HK$9.0b
Growth (TTM | estimate)
Revenue
18.9% | 22.9%
EBITDA
- | 5.6%
EBIT
183.2% | 6.8%
Net Income
80.4% | 30.6%
Free Cash Flow
28.8%
Margin (TTM | estimate)
Gross
23.8%
EBITDA
- | 5.1%
EBIT
6.0%
Net
7.3% | 7.6%
Free Cash Flow
12.7%
More
EPS
HK$1.6
FCF per Share
HK$2.8
Short interest
-
Employees
5k
Rev per Employee
HK$13.9m
Show more

Is JD Health International a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

JD Health International Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a JD Health International forecast:

21x Buy
91%
2x Hold
9%

Analyst Opinions

23 Analysts have issued a JD Health International forecast:

Buy
91%
Hold
9%

Financial data from JD Health International

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
71,172 71,172
19% 19%
100%
- Direct Costs 54,227 54,227
17% 17%
76%
16,945 16,945
25% 25%
24%
- Selling and Administrative Expenses 12,508 12,508
11% 11%
18%
- Research and Development Expense 1,554 1,554
13% 13%
2%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 4,280 4,280
183% 183%
6%
Net Profit 5,161 5,161
80% 80%
7%

In millions HKD.

Don't miss a Thing! We will send you all news about JD Health International directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

JD Health International, Inc. operates as an online healthcare platform and retail pharmacy company. Its technology-driven platform is cantered on the supply chain of pharmaceutical and healthcare products and healthcare services, encompassing a user’s full life span for all healthcare needs. The firm's retail pharmacy business operates through three models: direct sales, online marketplace and Omni channel initiative. It offers comprehensive online healthcare services, such as online consultation and prescription renewal, chronic disease management, family doctor and consumer healthcare. Its platform allows doctors to practice multisite, acquire and manage targeted patients, conduct healthcare research, exchange academic and clinical knowledge and improve diagnostic and treatment skills. The company was founded on November 30, 2018 and is headquartered in Beijing, China.

Head office Cayman Islands
CEO En Jin
Employees 4,572
Founded 2018
Website ir.jdhealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today